Proton Beam Radiotherapy for Pediatric Gliomas: Early Outcomes and Dose Comparison
- Author:
Hyeon Kang KOH
1
;
Byung Jun MIN
;
Jeong Hoon PARK
;
Kwan Ho CHO
;
Hyeon Jin PARK
;
Sang Hoon SHIN
;
Joo Young KIM
Author Information
1. Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea. bjmin.kr@gmail.com
- Publication Type:Original Article
- Keywords:
Proton beam therapy;
Glioma;
Pediatrics;
Organ sparing treatment
- MeSH:
Astrocytoma;
Brain Stem;
Child;
Follow-Up Studies;
Glioblastoma;
Glioma;
Humans;
Organ Sparing Treatments;
Pediatrics;
Proton Therapy;
Protons
- From:Clinical Pediatric Hematology-Oncology
2013;20(1):40-50
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Proton beam radiotherapy (PBT) has shown to provide high radiation dose to tumors and to save surrounding normal tissues because of its physical characteristics, Bragg peak. In the current study, we report the early outcomes for pediatric patients with intracranial gliomas treated with PBT and compared PBT plan (pencil beam scanning and double scattering) with intensity modulated radiotherapy (IMRT) plan and three dimensional-conformal radiotherapy (3D-CRT) plan.METHODS: Clinical data from 18 consecutive children with intracranial gliomas who underwent PBT from May 2007 to April 2012 was collected. The median follow-up duration was 16 months (range 6-69).RESULTS: There were 9 patients with brain stem glioma, 2 patients with optic pathway glioma, 2 patients with low grade glioma (LGG), 2 patients with anaplastic astrocytoma (AA) and 3 patients with glioblastoma multiforme (GBM). The median overall survival for patients with brain stem glioma was 11 months. Patients with optic pathway glioma, LGG or AA were all alive without progression except one patient. Among patients with GBM, one patient had no evidence of disease 25 months after PBT. When PBT plan was compared to those of IMRT and 3D-CRT for patients with LGG or AA and one patient with brain stem glioma by DVH analysis, PBT showed better sparing effect on normal tissue compared to IMRT and 3D-CRT, especially in low dose area.CONCLUSION: PBT could be delivered safely and effectively to pediatric patients with gliomas. For confirming the clinical benefits of PBT, further follow-up is necessary.
